- Home
- KNSA vs SILA Comparison
KNSA vs SILA Comparison
Compare KNSA & SILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- SILA
- Stock Information
- Founded
- KNSA 2015
- SILA 2013
- Country
- KNSA United Kingdom
- SILA United States
- Employees
- KNSA N/A
- SILA N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- SILA
- Sector
- KNSA Health Care
- SILA
- Exchange
- KNSA Nasdaq
- SILA NYSE
- Market Cap
- KNSA 1.6B
- SILA 1.4B
- IPO Year
- KNSA 2018
- SILA N/A
- Fundamental
- Price
- KNSA $23.09
- SILA $26.47
- Analyst Decision
- KNSA Strong Buy
- SILA Strong Buy
- Analyst Count
- KNSA 6
- SILA 3
- Target Price
- KNSA $37.17
- SILA $28.67
- AVG Volume (30 Days)
- KNSA 684.1K
- SILA 404.3K
- Earning Date
- KNSA 04-22-2025
- SILA 05-21-2025
- Dividend Yield
- KNSA N/A
- SILA 4.53%
- EPS Growth
- KNSA N/A
- SILA 87.50
- EPS
- KNSA N/A
- SILA 0.75
- Revenue
- KNSA $423,239,000.00
- SILA $186,856,000.00
- Revenue This Year
- KNSA $37.21
- SILA $6.10
- Revenue Next Year
- KNSA $1.38
- SILA $11.37
- P/E Ratio
- KNSA N/A
- SILA $35.29
- Revenue Growth
- KNSA 56.60
- SILA N/A
- 52 Week Low
- KNSA $16.56
- SILA $20.20
- 52 Week High
- KNSA $28.15
- SILA $26.75
- Technical
- Relative Strength Index (RSI)
- KNSA 60.12
- SILA N/A
- Support Level
- KNSA $22.62
- SILA N/A
- Resistance Level
- KNSA $23.42
- SILA N/A
- Average True Range (ATR)
- KNSA 0.75
- SILA 0.00
- MACD
- KNSA -0.01
- SILA 0.00
- Stochastic Oscillator
- KNSA 68.88
- SILA 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About SILA SILA REALTY TRUST INC
Sila Realty Trust Inc is a real estate investment trust. Its investment objective is to pay regular cash distributions to stockholders and to preserve, protect, and return capital contributions to stockholders. The company owns and manages healthcare assets. The company generates revenue from real estate investments in healthcare properties.